Zach Serber on product launch
From Synthetic Biology - fact or fiction? · · DMCBiotech
“We made the first announcement about it when it's actually on the market when you can buy it — I hope that there will be other companies that take that stance that have to acknowledge that there is a lot of skepticism and the surest way to turn around that skepticism is to show up with a product developed with your technology.”
On , Zach Serber, Cofounder at Zymergen, spoke about product launch during Synthetic Biology - fact or fiction? on DMCBiotech.
About Zach Serber
Zach Serber, cofounder of Zymergen, has described synthetic biology as "unquestionably fact" while acknowledging that the field has been associated with hype and past failures. In a 2020 panel, he noted that Zymergen initially avoided the term "synthetic biology" because of its association with money-losing ventures, and said the company kept a low profile for years, only announcing its first product — a flexible polyamide film for consumer electronics — when it was already on the market. Serber has emphasized the importance of demonstrating results rather than making promises, and has argued that a strong profit motive is necessary to attract new entrants to the industry. In earlier talks from 2015 and 2016, Serber described Zymergen's approach as "radical empiricism," combining microbe engineering with software and automation to search for commercially useful genetic perturbations. He stated that the company was prototyping 360 novel biomolecules with DARPA support, focusing on materials with fast adoption cycles and low regulatory hurdles, such as adhesives and coatings. Serber has said that biology can provide a richer palette of chemicals than petroleum, and that Zymergen aims to make biology "the petroleum of the future" by producing superior materials, medicines, and agricultural products without reliance on fossil fuels.